FDA Approves St. Jude Medical’s New Facility in Puerto Rico

Manufacturing plant will produce pacemakers and cardiac leads

By: Michael Barbella

Managing Editor

St. Jude Medical, Inc. announced that the US Food and Drug Administration has approved its new facility in Arecibo, Puerto Rico, for the manufacturing of pacemakers and cardiac leads. The approval followed a six-month review that included an on-site evaluation by FDA inspectors.

The company said the 150,000 square-foot facility, located in Arecibo’s Santana Industrial Park, will initially be used to produce St. Jude Medical pacemakers and cardiac leads for domestic and international markets. The company also plans to begin manufacturing implantable cardioverter defibrillators at the facility later this year.

The plant also will expand St. Jude Medical’s cardiac rhythm management manufacturing capacity and is expected to create at least 1,250 new jobs within the next three years.

SOURCE: RTTNews

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters